You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
Authors:
Matthew Walters, Jacqueline Taylor, Adrian Brady
Thrombolytic therapy for acute ischaemic stroke improves outcome in a highly selected group of patients. It will shortly be licensed in the UK for this indication. Implementation of this treatment will be difficult as current stroke services are ill-equipped to meet the challenges associated with aggressive management of hyperacute stroke.
This article evaluates the published literature concerning thrombolytic therapy in the context of ischaemic stroke and briefly discuss the obstacles which prevent more widespread use of this treatment in the UK. It also considers the effect of age on efficacy and tolerability of thrombolytic therapy.
There are currently no comments for this article - leave a comment
You must be logged in to post a comment.
Not yet a member? Register now for free.
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
You need to be a member to download PDF's.
Sign up for free membership, or log in.
Find out more about our membership benefits